Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Chun Hang Tang"'
Autor:
Chun Hang Tang, Beulah Ji, Ana Malvar, Y K Onno Teng, Brad H. Rovin, Jennifer A Gilbride, Gabriel Contreras, Richard Furie, David M. Roth, Xueqing Yu, Damon Bass, Yulia Green, Tania Gonzalez-Rivera
Publikováno v:
Kidney International, 101(2), 403-413. ELSEVIER SCIENCE INC
We performed a post hoc analysis of the Belimumab International Study in Lupus Nephritis (BLISS-LN), a Phase 3, multinational, double-blind, 104-week trial, in which 448 patients with lupus nephritis were randomized to receive intravenous belimumab 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9139836592dd4624cd96a6d2829ad0e
https://doi.org/10.1016/j.kint.2021.08.027
https://doi.org/10.1016/j.kint.2021.08.027
Autor:
Xueqing Yu, Nan Chen, Jun Xue, Chi Chiu Mok, Sang-Cheol Bae, Xiaomei Peng, Wei Chen, Hong Ren, Xiao Li, Kajohnsak Noppakun, Jennifer A. Gilbride, Yulia Green, Beulah Ji, Chang Liu, Anuradha Madan, Mohamed Okily, Chun-Hang Tang, David A. Roth
Publikováno v:
American Journal of Kidney Diseases. 81:294-306.e1
Belimumab improved renal outcomes in patients with active lupus nephritis (LN) in BLISS-LN, leading to its approval in the USA and EU. As data on treatment of East Asian patients with LN are limited, we evaluated the efficacy and safety of belimumab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::493bdc583e4ce3e883d32e5b1aac387b
https://doi.org/10.1053/j.ajkd.2022.06.013
https://doi.org/10.1053/j.ajkd.2022.06.013